Study of the Role of Genetic Modifiers in Hemoglobinopathies
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 2 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
This study will investigate the role of genetic modifiers in hemoglobinopathies through a large-scale, multi-ethnic genome-wide association study (GWAS).
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Official eligibility criteria
Inclusion Criteria: * Clinical diagnosis of an inherited hemoglobinopathy, including sickle cell disease (SCD), β-thalassemia, and α-thalassemia; all genotypes will be considered. * Age ≥ 2 years old at the time of the collection of the phenotypic data. * There will be no limits on study participants in terms of gender, ethnicity, morbidities. Exclusion Criteria: * Patients treated with stem cell transplantation or genetic therapy. * Age \< 2 years old at the time of the collection of the phenotypic data. * Patient or legal representative for minors unwilling or unable to give consent.
Study sites (1)
MA
- Boston Children's Hospital · Boston, MA 02115Natasha Archer, MD · Study contactMore trials in Boston